IMPACT OF EARLY ART INITIATION ON PERFORMANCE OF CROSS-SECTIONAL INCIDENCE ASSAYS
Antiretroviral treatment (ART) can impact results obtained with assays used for cross-sectional HIV incidence estimation, causing inaccurate HIV incidence estimates. We evaluated the relationship between the timing of ART initiation and the performance of two HIV incidence assays (the Sedia LAg-Avidity assay and the Johns Hopkins modified BioRad-Avidity assay). We analyzed 302 samples from 55…